Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-29,442
Closed -$706K – 1613
2015
Q1
$706K Buy
29,442
+1,402
+5% +$34.7K ﹤0.01% 1279
2014
Q4
$742K Buy
+28,040
New +$720K ﹤0.01% 1276
2014
Q3
– Sell
-56,080
Closed -$1.46M – 1608
2014
Q2
$1.46M Hold
56,080
– – 0.01% 958
2014
Q1
$1.34M Sell
56,080
-32,246
-37% -$679K 0.01% 984
2013
Q4
$1.73M Sell
88,326
-12,618
-13% -$254K 0.01% 835
2013
Q3
$2.08M Sell
100,944
-5,608
-5% -$123K 0.01% 787
2013
Q2
$2.35M Buy
+106,552
New +$2.58M 0.02% 707

Other funds holding EXC

Nuveen's EXC Position: Q2 2026 in Review

Nuveen increased its Exelon (EXC) stake by 4.9% in Q2 2026, buying an estimated $10M and bringing the position to 4,620,165 shares worth $215M. The position accounts for 0.05% of the portfolio, ranked #260.

Nuveen first reported a position in EXC in Q2 2013 and has held it in 53 quarters since. The position peaked at $327M in Q3 2019. 1,292 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Nuveen held 4,620,165 shares of Exelon worth $215M as of Q2 2026.
  • Nuveen bought 216,604 Exelon shares in Q2 2026, an estimated $10M.
  • Exelon made up 0.05% of Nuveen's portfolio in Q2 2026, its #260 holding.
  • Nuveen first reported a position in Exelon in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's Exelon position peaked at $327M in Q3 2019.
  • 1,292 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.